4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0000950170-25-075539
Director sold 3,000 shares at $107.49 ($322,473)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Coleman Mark Director | 2025-05-20 | Sale | −3,000 | $107.49 | $322,473 | 54,137 | D: show line 1 in the form |
| Open-market sales · 3,000 sh · avg $107.49 · $322,473 | |||||||
Loading xslF345X05/ownership.xml…